血浆和血清中的循环核酸作为癌症的非侵入性检测手段：开展大规模临床研究的时候到了吗？ - Suppr

Suppr

超能文献

Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?

作者信息

Anker Philippe, Mulcahy Hugh, Stroun Maurice

机构信息

Extracellular Biology Research Laboratory, Carouge/Geneva, Switzerland.

出版信息

Int J Cancer. 2003 Jan 10;103(2):149-52. doi: 10.1002/ijc.10791.

DOI:10.1002/ijc.10791

PMID:12455027

Abstract

摘要

相似文献

Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?

Int J Cancer. 2003 Jan 10;103(2):149-52. doi: 10.1002/ijc.10791.

Circulating nucleic acids (CNAs) and cancer--a survey.

Biochim Biophys Acta. 2007 Jan;1775(1):181-232. doi: 10.1016/j.bbcan.2006.10.001. Epub 2006 Oct 7.

Circulating nucleic acids as a tumor marker.

Histol Histopathol. 2002;17(3):937-43. doi: 10.14670/HH-17.937.

Plasma nucleic acids in the diagnosis and management of malignant disease.

Clin Chem. 2002 Aug;48(8):1186-93.

Circulating nucleic acids in cancer and pregnancy.

Methods. 2010 Apr;50(4):302-7. doi: 10.1016/j.ymeth.2010.02.004. Epub 2010 Feb 8.

Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.

J Mol Diagn. 2015 May;17(3):209-24. doi: 10.1016/j.jmoldx.2015.02.001.

RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma.

Genes Chromosomes Cancer. 2002 Dec;35(4):375-6. doi: 10.1002/gcc.10124.

Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy.

Cancer Sci. 2009 Feb;100(2):303-9. doi: 10.1111/j.1349-7006.2008.01021.x.

Diagnostic potential of circulating nucleic acids for oncology.

Expert Rev Mol Diagn. 2003 Jul;3(4):431-42. doi: 10.1586/14737159.3.4.431.

Circulating nucleic acids in plasma and serum: past, present and future.

Curr Opin Mol Ther. 2004 Jun;6(3):273-8.

引用本文的文献

Rational design of on-chip gold plasmonic nanoparticles towards ctDNA screening.

Sci Rep. 2021 Jul 9;11(1):14185. doi: 10.1038/s41598-021-93207-7.

Diagnostic value of circulating cell-free mtDNA in patients with suspected thyroid cancer: ND4/ND1 ratio as a new potential plasma marker.

Mitochondrion. 2020 Nov;55:145-153. doi: 10.1016/j.mito.2020.09.007. Epub 2020 Oct 7.

Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer.

Oncol Lett. 2020 Feb;19(2):1551-1558. doi: 10.3892/ol.2019.11192. Epub 2019 Dec 9.

Isolation of circulating tumor cells in patients undergoing surgery for esophageal cancer and a specific confirmation method.

Oncol Lett. 2019 Apr;17(4):3817-3825. doi: 10.3892/ol.2019.10017. Epub 2019 Feb 6.

Advances in liquid biopsy on-chip for cancer management: Technologies, biomarkers, and clinical analysis.

Crit Rev Clin Lab Sci. 2018 May;55(3):140-162. doi: 10.1080/10408363.2018.1425976. Epub 2018 Feb 1.

Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers.

Arthritis Res Ther. 2017 May 2;19(1):85. doi: 10.1186/s13075-017-1295-z.

On-chip wavelength multiplexed detection of cancer DNA biomarkers in blood.

Biomicrofluidics. 2016 Dec 15;10(6):064116. doi: 10.1063/1.4968033. eCollection 2016 Nov.

Chimeric External Control to Quantify Cell Free DNA in Plasma Samples by Real Time PCR.

Avicenna J Med Biotechnol. 2016 Apr-Jun;8(2):84-90.

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies.

Int J Mol Sci. 2016 Apr 27;17(5):627. doi: 10.3390/ijms17050627.

MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential.

Curr Genomics. 2015 Oct;16(5):349-58. doi: 10.2174/1389202916666150707160147.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?

作者信息

Anker Philippe, Mulcahy Hugh, Stroun Maurice

机构信息

Extracellular Biology Research Laboratory, Carouge/Geneva, Switzerland.

出版信息

Int J Cancer. 2003 Jan 10;103(2):149-52. doi: 10.1002/ijc.10791.

DOI:10.1002/ijc.10791

PMID:12455027

Abstract

摘要

相似文献

Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?

Int J Cancer. 2003 Jan 10;103(2):149-52. doi: 10.1002/ijc.10791.

Circulating nucleic acids (CNAs) and cancer--a survey.

Biochim Biophys Acta. 2007 Jan;1775(1):181-232. doi: 10.1016/j.bbcan.2006.10.001. Epub 2006 Oct 7.

Circulating nucleic acids as a tumor marker.

Histol Histopathol. 2002;17(3):937-43. doi: 10.14670/HH-17.937.

Plasma nucleic acids in the diagnosis and management of malignant disease.

Clin Chem. 2002 Aug;48(8):1186-93.

Circulating nucleic acids in cancer and pregnancy.

Methods. 2010 Apr;50(4):302-7. doi: 10.1016/j.ymeth.2010.02.004. Epub 2010 Feb 8.

Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.

J Mol Diagn. 2015 May;17(3):209-24. doi: 10.1016/j.jmoldx.2015.02.001.

RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma.

Genes Chromosomes Cancer. 2002 Dec;35(4):375-6. doi: 10.1002/gcc.10124.

Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy.

Cancer Sci. 2009 Feb;100(2):303-9. doi: 10.1111/j.1349-7006.2008.01021.x.

Diagnostic potential of circulating nucleic acids for oncology.

Expert Rev Mol Diagn. 2003 Jul;3(4):431-42. doi: 10.1586/14737159.3.4.431.

Circulating nucleic acids in plasma and serum: past, present and future.

Curr Opin Mol Ther. 2004 Jun;6(3):273-8.

引用本文的文献

Rational design of on-chip gold plasmonic nanoparticles towards ctDNA screening.

Sci Rep. 2021 Jul 9;11(1):14185. doi: 10.1038/s41598-021-93207-7.

Diagnostic value of circulating cell-free mtDNA in patients with suspected thyroid cancer: ND4/ND1 ratio as a new potential plasma marker.

Mitochondrion. 2020 Nov;55:145-153. doi: 10.1016/j.mito.2020.09.007. Epub 2020 Oct 7.

Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer.

Oncol Lett. 2020 Feb;19(2):1551-1558. doi: 10.3892/ol.2019.11192. Epub 2019 Dec 9.

Isolation of circulating tumor cells in patients undergoing surgery for esophageal cancer and a specific confirmation method.

Oncol Lett. 2019 Apr;17(4):3817-3825. doi: 10.3892/ol.2019.10017. Epub 2019 Feb 6.

Advances in liquid biopsy on-chip for cancer management: Technologies, biomarkers, and clinical analysis.

Crit Rev Clin Lab Sci. 2018 May;55(3):140-162. doi: 10.1080/10408363.2018.1425976. Epub 2018 Feb 1.

Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers.

Arthritis Res Ther. 2017 May 2;19(1):85. doi: 10.1186/s13075-017-1295-z.

On-chip wavelength multiplexed detection of cancer DNA biomarkers in blood.

Biomicrofluidics. 2016 Dec 15;10(6):064116. doi: 10.1063/1.4968033. eCollection 2016 Nov.

Chimeric External Control to Quantify Cell Free DNA in Plasma Samples by Real Time PCR.

Avicenna J Med Biotechnol. 2016 Apr-Jun;8(2):84-90.

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies.

Int J Mol Sci. 2016 Apr 27;17(5):627. doi: 10.3390/ijms17050627.

MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential.

Curr Genomics. 2015 Oct;16(5):349-58. doi: 10.2174/1389202916666150707160147.